Aktiesnakken — Juni 2016
-
There was a significant 22% reduction in cardiovascular death with Victoza
treatment vs placebo (95% CI: 0.66; 0.93, p=0.007) and reductions in non-fatal myocardial infarction (HR=0.88, 95% CI: 0.75; 1.03, p=0.11) and non-fatal stroke (HR=0.89, 95% CI: 0.72; 1.11, p=0.30).1, 2 -
Er det godt eller skide godt ??
-
Åbenbart så er disse Victoza Data nok som forventet.
-
God morgen.
-
En god gennem omkring data på Victosa. http://www.proinvestor.com/investornyt/377774/novo-victoza-vaekker-laeger-og-diabetikere-til-live
-
gennemgang
-
I forhold til forventningerne fra Citigroup er data lidt skuffende: https://www.landbobanken.dk/investering/aktiefokus
-
Godmorgen fellas
-
Fra Danske Bank: "NOVO NORDISK: robust data from Leader trail, 13% reduction for GPP-1 even if
we hoped for a bit more good enough, +tive effect on all CV
endpoints. We reiterate BUY & TP 470." -
Nu er det svært at spå især om fremtiden men mine forventninger til i dag er, at 1100 niveau skal testes endnu en gang. Afvises den endnu en gang, så er der gode mulighed for, at vi får lidt ro på indtil i næste uge, hvor brexit meningsmålingerne vil styre kursen.
-
Det gælder helt klart, at laksepriserne ikke må blive for høje før forbrugerne tænker på substitution
-
-
Markant opjustering fra SP Group https://www.nordnet.dk/mux/web/analys/nyheter/visaNyhet.html?itemid=289364007&sourcecode=omxnews
-
De er så lækkert et selskab
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind